Cleared Traditional

K926101 - PHOENIX OPTI-MAX DENT IMPL W/PLAS-SPRAY TITA/HYDRO

K926101 is an FDA 510(k) clearance for PHOENIX OPTI-MAX DENT IMPL W/PLAS-SPRAY..., manufactured by Phoenix Dental, Inc.. The device is a Class 2 Dental device with product code DZE cleared through the Traditional 510(k) pathway after a 567-day FDA review.

K926101 · Phoenix Dental, Inc. · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1994
Decision
567d
Days
Class 2
Risk

K926101 is an FDA 510(k) clearance for the PHOENIX OPTI-MAX DENT IMPL W/PLAS-SPRAY TITA/HYDRO. Classified as Implant, Endosseous, Root-form (product code DZE), Class II - Special Controls.

Submitted by Phoenix Dental, Inc. (San Diego, US). The FDA issued a Cleared decision on June 23, 1994 after a review of 567 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3640 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Dental submissions.

View all Phoenix Dental, Inc. devices

FDA 510(k) Submission Details - K926101

510(k) Number K926101 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 03, 1992
Decision Date June 23, 1994
Days to Decision 567 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
440d slower than avg
Panel avg: 127d · This submission: 567d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DZE Device Classification - Class 2, Special Controls

Product Code DZE Implant, Endosseous, Root-form
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - DZE Implant, Endosseous, Root-form

All 1091
Devices cleared under the same product code (DZE) and FDA review panel - the closest regulatory comparables to K926101.
INTERPORE CYLINDRICAL HEX HYDROXYAPATITE COATED IMPLANT, 3.3 MM DIAM.
K922872 · Interpore Intl. · Jul 1994
SUSTAIN HEX HA-COATED CYLINDER ENDOSSEOUS IMPLANT SYSTEM
K941554 · Lifecore Biomedical, Inc. · Jul 1994
RESTORE HEX CYLINDER ENDOSSEOUS SYSTEM
K931468 · Lifecore Biomedical, Inc. · Jul 1994
IMPLANT INNOVATION PRE-ANGLED ABUTMENT SYSTEM
K932123 · Implant Innovations International, Inc. · May 1994
BRANEMARK SYST. HAND INST. DIA 297 & SDIA 276
K925483 · Nobelpharma USA, Inc. · May 1994
TAPERED ABUTMENT AND RELATED COMPONENTS
K933969 · Implant Innovations, Inc. · Apr 1994